Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Nanologix collaborates with Saudi company to distribute Nanologix products in Arabian Gulf region

NanoLogix, Inc. an innovator in the rapid detection, identification of live bacteria, and determination of their antibiotic resistance and sensitivity, announces that they are working with Nasaem-Aljazira, a Saudi Arabian company headquartered in Riyadh, to establish exclusive distribution and/or manufacturing of NanoLogix products in Saudi Arabia and the Arabian Gulf region, also known as the Gulf Cooperation Council (GCC) area.

4 Dec 2013

Scientists identify enzyme that could lead to better treatment of Alzheimer's disease

St. Jude Children's Research Hospital scientists have identified an enzyme that can halt or possibly even reverse the build-up of toxic protein fragments known as plaques in the brains of mice with Alzheimer's disease. The research appeared in a recent edition of the scientific journal Nature Communications.

3 Dec 2013

Experts explain how to prevent heartburn during holidays

Attracted by the decadent treats, fried meats, and festive cocktails of the Thanksgiving-to-New-Year feast, heartburn can be an unwelcome guest during the holidays. According to the American Society for Gastrointestinal Endoscopy, acid reflux affects about 30 million Americans.

3 Dec 2013

Tips to protect yourself from getting sick during cold and flu season

As you travel to visit friends and family this holiday season, don't leave home without the hand sanitizer. During cold and flu season, that's one of three things you can do to protect yourself from getting sick you're on the go.

3 Dec 2013

Leapfrog announces list of 2013 Top Hospitals

The Leapfrog Group announced its list of Top Hospitals at its Annual Meeting today, highlighting the diversity of hospitals represented nationwide. Widely cited as the nation's most competitive hospital quality award, the Top Hospitals designation recognizes hospitals that deliver the highest quality care by preventing medical errors, reducing mortality for high-risk procedures like heart bypass surgery, and reducing readmissions for patients being treated for conditions like pneumonia and heart attack.

3 Dec 2013

MiniVax wins $20,000 in NOBIC’s second annual BioChallenge business competition

MiniVax, Inc. (MiniVax) participated in the New Orleans BioInnovation Center's (NOBIC) second annual BioChallenge, a business competition part of the three-day Innovation Louisiana 2013 conference.

3 Dec 2013

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Forest Laboratories Holdings Limited, a wholly owned subsidiary of Forest Laboratories, Inc. today announced that the company is acquiring exclusive rights in the United States for Saphris (asenapine) sublingual tablets, a treatment for adult patients with schizophrenia or acute bipolar mania, from Merck Sharp & Dohme B.V., a wholly owned subsidiary of Merck & Co., Inc.

3 Dec 2013

Newly identified protein could prove promising new drug target for AIDS

Researchers have identified a protein that causes loss of function in immune cells combatting HIV. The scientists report in a paper appearing online Dec. 2 in the Journal of Clinical Investigation that the protein, Sprouty-2, is a promising target for future HIV drug development, since disabling it could help restore the cells' ability to combat the virus that causes AIDS.

2 Dec 2013

Vitamin D status optimization could cut pneumonia cases

A large US population-based study confirms that serum 25-hydroxyvitamin D levels are associated with the risk for community-acquired pneumonia.

2 Dec 2013

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

Visterra, Inc., a developer of novel antibody therapeutics to prevent and treat major infectious diseases, today announced that it has secured an exclusive patent license from Massachusetts Institute of Technology to a family of early-stage monoclonal antibodies that target dengue virus. These antibodies were developed by MIT in the laboratory of Dr. Ram Sasisekharan, a founder of Visterra, using novel protein engineering approaches. Visterra will apply its proprietary network analysis technology to develop a human monoclonal antibody product candidate capable of broadly neutralizing all four dengue virus serotypes.

2 Dec 2013

New biomarkers to improve diagnostics of prostate cancer

New biomarkers will improve diagnostics of endemic diseases in future, such as prostate cancer. Their mission: to recognize the tumor earlier and classify it more precisely - thereby helping avoid unnecessary operations.

2 Dec 2013

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Visterra, Inc., a developer of novel therapeutics to prevent and treat major infectious diseases, today announced that it has received $8.1 million in proceeds from an upsized and final closing of its Series A financing round. The company also announced that it has deepened its executive management team by appointing two industry veterans to newly created roles, which follows the recent appointment of Brian Pereira, M.D. as President and Chief Executive Officer of Visterra this past summer.

2 Dec 2013

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Nanosponges that soak up a dangerous pore-forming toxin produced by MRSA (methicillin-resistant Staphylococcus aureus) could serve as a safe and effective vaccine against this toxin. This "nanosponge vaccine" enabled the immune systems of mice to block the adverse effects of the alpha-haemolysin toxin from MRSA-both within the bloodstream and on the skin. Nanoengineers from the University of California, San Diego described the safety and efficacy of this nanosponge vaccine in the December 1 issue of Nature Nanotechnology.

2 Dec 2013

Food safety tips for people with HIV/AIDS

December 1, 2013 is World AIDS Day and while the connection between HIV/AIDS (Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome) and food safety may not seem obvious, it's actually crucial.

30 Nov 2013

Researchers identify gene responsible for malfunctions in fear-related memory system

A study published recently in the Journal of Neuroscience points, for the first time, to the gene trkC as a factor in susceptibility to the disease. The researchers define the specific mechanism for the formation of fear memories which will help in the development of new pharmacological and cognitive treatments.

29 Nov 2013

Medical Research Council should do more in the development of gold standard for clinical trial design

More should be done to celebrate the role of one of Britain’s leading institutions, the Medical Research Council, in the development of the gold standard for clinical trial design. Sir Iain Chalmers, writing in the Journal of the Royal Society of Medicine, questions the apparent reluctance of the MRC to take credit for its ground-breaking work in the design and management of randomised multicentre controlled clinical trials in the 1950s.

28 Nov 2013

State highlights: S.C. clinic a model for free care; Mont. doctor's push to treat mine workers sickened by asbestos; fast food consumption in Calif. kids

What began two decades ago on Hilton Head Island as a free clinic using retired physicians and volunteers to care for the working poor has become a model for dozens of similar clinics nationwide. At a time when the nation debates how to pay for care, there are now 96 Volunteers in Medicine Clinics in 29 states (Smith, 11/27).

28 Nov 2013

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

Nanologix collaborates with Saudi company to distribute Nanologix products in Arabian Gulf region

Scientists identify enzyme that could lead to better treatment of Alzheimer's disease

Experts explain how to prevent heartburn during holidays

Tips to protect yourself from getting sick during cold and flu season

Leapfrog announces list of 2013 Top Hospitals

MiniVax wins $20,000 in NOBIC’s second annual BioChallenge business competition

Forest Laboratories to acquire exclusive rights in the U.S. for Saphris sublingual tablets

Newly identified protein could prove promising new drug target for AIDS

Vitamin D status optimization could cut pneumonia cases

Visterra secures exclusive patent license for promising dengue virus antibodies from MIT

New biomarkers to improve diagnostics of prostate cancer

Visterra gets $8.1M in proceeds from upsized and final closing of Series A financing round

Nanosponge vaccine blocks adverse effects of alpha-haemolysin toxin from MRSA

Food safety tips for people with HIV/AIDS

Researchers identify gene responsible for malfunctions in fear-related memory system

Medical Research Council should do more in the development of gold standard for clinical trial design

State highlights: S.C. clinic a model for free care; Mont. doctor's push to treat mine workers sickened by asbestos; fast food consumption in Calif. kids

Walk-in clinics staffed by nurses can reduce health care costs, says URI professor

How Washington State made its health insurance exchange work; Philly plans big exchange push

Loyola dermatologist offers skin care tips for holidays

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in